![]()
|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 16, 7594-7604, Jun, 1987
AJ Lusis, BA Taylor, D Quon, S Zollman and RC LeBoeuf
We report the identification and partial characterization of polymorphisms
among inbred strains of mice affecting several aspects of the expression of
apolipoproteins B and E (apoB and apoE), the major proteins of low density
lipoproteins (LDL) and very low density lipoproteins (VLDL). These
polymorphisms include differences in the levels of the lipoproteins and
apolipoproteins on both chow and high fat diets, differences in their
response to a high fat diet challenge, and differences in the relative
levels of the two molecular weight species of apoB. Although most strains
exhibited a large increase in plasma LDL and VLDL in response to a high fat
diet, the levels of apoB and apoE mRNA were either unaffected or, in some
cases, decreased slightly. Also, the levels of apoB and apoE mRNA were not
correlated among strains with the levels of the apolipoproteins in plasma,
suggesting that genetic control occurs primarily at the level of
lipoprotein catabolism. Elucidation of the precise mechanisms involved in
the differences will require genetic analysis. Toward this end, we have
identified DNA polymorphisms for apoB and apoE and have used these in
segregation analysis to determine the chromosomal locations of the apoB and
apoE structural genes in mice. The gene for apoB, designated Apob, resides
in the proximal region of chromosome 12 linked to genes for ribosomal RNA
and aryl hydrocarbon hydroxylase. The gene for apoE, designated Apoe, is
located on chromosome 7, linked to genes for glucose phosphate isomerase
and peptidase 4. Previously, we mapped the structural genes for
apolipoproteins A-I and A-II to mouse chromosomes 9 and 1, respectively,
and thus, the four loci encoding mammalian apolipoproteins have now been
located in the mouse. These loci are homologous to the loci encoding
apolipoproteins in humans as judged by the conservation of linked markers.
A correlation was observed between a unique apoB allele and
"responsiveness" to a high fat diet challenge. There were no obvious
associations of apoB, apoE, or LDL/VLDL phenotypes or genotypes with
diet-induced atherosclerosis among strains surveyed. These results clarify
the organization and regulation of the genes for apoB and apoE, and they
provide information about the naturally occurring polymorphisms affecting
their expression.
Genetic factors controlling structure and expression of apolipoproteins B and E in mice
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Degrace, L. Demizieux, Z.-y. Du, J. Gresti, L. Caverot, L. Djaouti, T. Jourdan, B. Moindrot, J.-C. Guilland, J.-F. Hocquette, et al. Regulation of Lipid Flux between Liver and Adipose Tissue during Transient Hepatic Steatosis in Carnitine-depleted Rats J. Biol. Chem., July 20, 2007; 282(29): 20816 - 20826. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Garver, C. Xie, J. J. Repa, S. D. Turley, and J. M. Dietschy Niemann-Pick C1 expression is not regulated by the amount of cholesterol flowing through cells in the mouse J. Lipid Res., August 1, 2005; 46(8): 1745 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fryer, R. B. DeMattos, L. M. McCormick, M. A. O'Dell, M. L. Spinner, K. R. Bales, S. M. Paul, P. M. Sullivan, M. Parsadanian, G. Bu, et al. The Low Density Lipoprotein Receptor Regulates the Level of Central Nervous System Human and Murine Apolipoprotein E but Does Not Modify Amyloid Plaque Pathology in PDAPP Mice J. Biol. Chem., July 8, 2005; 280(27): 25754 - 25759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wahrle, H. Jiang, M. Parsadanian, J. Legleiter, X. Han, J. D. Fryer, T. Kowalewski, and D. M. Holtzman ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE J. Biol. Chem., September 24, 2004; 279(39): 40987 - 40993. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ouguerram, M. Chetiveaux, Y. Zair, P. Costet, M. Abifadel, M. Varret, C. Boileau, T. Magot, and M. Krempf Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations in PCSK9 Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1448 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Schreyer, D. E. Cummings, G. S. McKnight, and R. C. LeBoeuf Mutation of the RII{beta} Subunit of Protein Kinase A Prevents Diet-Induced Insulin Resistance and Dyslipidemia in Mice Diabetes, November 1, 2001; 50(11): 2555 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. S. de Villiers, L. Cai, N. R. Webb, M. C. de Beer, D. R. van der Westhuyzen, and F. C. de Beer CD36 does not play a direct role in HDL or LDL metabolism J. Lipid Res., August 1, 2001; 42(8): 1231 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ko, T.-L. Lee, P. W. Lau, J. Li, B. T. Davis, E. Voyiaziakis, D. B. Allison, S. C. Chua , Jr., and L.-S. Huang Two novel quantitative trait loci on mouse chromosomes 6 and 4 independently and synergistically regulate plasma apoB levels J. Lipid Res., May 1, 2001; 42(5): 844 - 855. [Abstract] [Full Text] |
||||
![]() |
C. C. Hedrick, L. W. Castellani, H. Wong, and A. J. Lusis In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions J. Lipid Res., April 1, 2001; 42(4): 563 - 570. [Abstract] [Full Text] |
||||
![]() |
C. C. Hedrick, K. Hassan, G. P. Hough, J. Yoo, S. Simzar, C. R. Quinto, S.-M. Kim, A. Dooley, S. Langi, S. Y. Hama, et al. Short-Term Feeding of Atherogenic Diet to Mice Results in Reduction of HDL and Paraoxonase That May Be Mediated by an Immune Mechanism Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1946 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mouzeyan, J. Choi, H. Allayee, X. Wang, J. Sinsheimer, J. Phan, L. W. Castellani, K. Reue, A. J. Lusis, and R. C. Davis A locus conferring resistance to diet-induced hypercholesterolemia and atherosclerosis on mouse chromosome 2 J. Lipid Res., April 1, 2000; 41(4): 573 - 582. [Abstract] [Full Text] |
||||
![]() |
C. Desurmont, J.-M. Caillaud, F. Emmanuel, P. Benoit, J. C. Fruchart, G. Castro, D. Branellec, J.-M. Heard, and N. Duverger Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 435 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R Mensenkamp, M. C Jong, H. van Goor, M. J. A. van Luyn, V. Bloks, R. Havinga, P. J. Voshol, M. H. Hofker, K. W. van Dijk, L. M. Havekes, et al. Apolipoprotein E Participates in the Regulation of Very Low Density Lipoprotein-Triglyceride Secretion by the Liver J. Biol. Chem., December 10, 1999; 274(50): 35711 - 35718. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Voyiaziakis, C. Ko, S. M. O'Rourke, and L.-S. Huang Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains J. Lipid Res., November 1, 1999; 40(11): 2004 - 2012. [Abstract] [Full Text] |
||||
![]() |
V. Briquet-Laugier, O. Ben-Zeev, A. White, and M. H. Doolittle cld and lec23 are disparate mutations that affect maturation of lipoprotein lipase in the endoplasmic reticulum J. Lipid Res., November 1, 1999; 40(11): 2044 - 2058. [Abstract] [Full Text] |
||||
![]() |
A. H. Hasty, M. F. Linton, L. L. Swift, and S. Fazio Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance J. Lipid Res., August 1, 1999; 40(8): 1529 - 1538. [Abstract] [Full Text] |
||||
![]() |
E. Kim, P. Ambroziak, M. M. Veniant, R. L. Hamilton, and S. G. Young A Gene-targeted Mouse Model for Familial Hypobetalipoproteinemia. LOW LEVELS OF APOLIPOPROTEIN B mRNA IN ASSOCIATION WITH A NONSENSE MUTATION IN EXON 26 OF THE APOLIPOPROTEIN B GENE J. Biol. Chem., December 18, 1998; 273(51): 33977 - 33984. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, S. Bellosta, C. Langer, F. Bernini, R. E. Pitas, R. W. Mahley, G. Assmann, and A. von Eckardstein Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma PNAS, June 23, 1998; 95(13): 7585 - 7590. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Kirk, P. Sutherland, S. A. Wang, A. Chait, and R. C. LeBoeuf Dietary Isoflavones Reduce Plasma Cholesterol and Atherosclerosis in C57BL/6 Mice but not LDL Receptor-Deficient Mice J. Nutr., June 1, 1998; 128(6): 954 - 959. [Abstract] [Full Text] |
||||
![]() |
S. Swarnakar, M. E. Reyland, J. Deng, S. Azhar, and D. L. Williams Selective Uptake of Low Density Lipoprotein-Cholesteryl Ester Is Enhanced by Inducible Apolipoprotein E Expression in Cultured Mouse Adrenocortical Cells J. Biol. Chem., May 15, 1998; 273(20): 12140 - 12147. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mohammadi, J. Macri, R. Newton, T. Romain, D. Dulay, and K. Adeli Effects of Atorvastatin on the Intracellular Stability and Secretion of Apolipoprotein B in HepG2 Cells Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 783 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim and S. G. Young Genetically modified mice for the study of apolipoprotein B J. Lipid Res., April 1, 1998; 39(4): 703 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Macri Khosrow Adeli Conformational Changes in Apolipoprotein B Modulate Intracellular Assembly and Degradation of ApoB-Containing Lipoprotein Particles in HepG2 Cells Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2982 - 2994. [Abstract] [Full Text] |
||||
![]() |
C. P. Carter, P. N. Howles, and D. Y. Hui Genetic Variation in Cholesterol Absorption Efficiency among Inbred Strains of Mice J. Nutr., July 1, 1997; 127(7): 1344 - 1348. [Abstract] [Full Text] |
||||
![]() |
E. I. Park, E. A. Paisley, H. J. Mangian, D. A. Swartz, M. Wu, P. J. O'Morchoe, S. R. Behr, W. J. Visek, and J. Kaput Lipid Level and Type Alter Stearoyl CoA Desaturase mRNA Abundance Differently in Mice with Distinct Susceptibilities to Diet-Influenced Diseases J. Nutr., April 1, 1997; 127(4): 566 - 573. [Abstract] [Full Text] |
||||
![]() |
J. Macri and K. Adeli Studies on Intracellular Translocation of Apolipoprotein B in a Permeabilized HepG2 System J. Biol. Chem., March 14, 1997; 272(11): 7328 - 7337. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J.M. van Vlijmen, K. W. van Dijk, H. B. van't Hof, P. J.J. van Gorp, A. van der Zee, H. van der Boom, M. L. Breuer, M. H. Hofker, and L. M. Havekes In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 right-arrow Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice J. Biol. Chem., November 29, 1996; 271(48): 30595 - 30602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Schreyer, J. J. Peschon, and R. C. LeBoeuf Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55 J. Biol. Chem., October 18, 1996; 271(42): 26174 - 26178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Stevenson, J. Marshall-Neff, B. Teng, C. B. Lee, S. Roy, and A. McClelland Phenotypic Correction of Hypercholesterolemia in ApoE-Deficient Mice by Adenovirus-Mediated In Vivo Gene Transfer Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 479 - 484. [Abstract] [Full Text] |
||||
![]() |
S. Zhang, R. Reddick, J. Piedrahita, and N Maeda Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science, October 16, 1992; 258(5081): 468 - 471. [Abstract] [PDF] |
||||
![]() |
M Yokode, R. Hammer, S Ishibashi, M. Brown, and J. Goldstein Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors Science, November 30, 1990; 250(4985): 1273 - 1275. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |